Basis for Design and Development of Platinum(IV) Anticancer Complexes

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTBasis for Design and Development of Platinum(IV) Anticancer ComplexesMatthew D. Hall, Howard R. Mellor, Richard Callaghan, and Trevor W. HambleyView Author Information Centre for Heavy Metals Research, School of Chemistry, The University of Sydney, New South Wales 2006, Australia, Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, Maryland 20893-4256, and Oxford Drug Resistance Group, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, U.K. Cite this: J. Med. Chem. 2007, 50, 15, 3403–3411Publication Date (Web):June 28, 2007Publication History Received12 March 2007Published online28 June 2007Published inissue 1 July 2007https://pubs.acs.org/doi/10.1021/jm070280uhttps://doi.org/10.1021/jm070280ureview-articleACS PublicationsCopyright © 2007 American Chemical SocietyRequest reuse permissionsArticle Views5547Altmetric-Citations393LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Cells,Ligands,Redox reactions,Toxicity Get e-Alerts